A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies
Clinical trial NCT02334748 · COMPLETED
Trial details
- NCT number
- NCT02334748
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-03
- Primary completion
- 2018-08-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.